These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 2565819)

  • 1. Role of dopamine D-1 and D-2 receptors in the regulation of neurotensin systems of the neostriatum and the nucleus accumbens.
    Merchant KM; Gibb JW; Hanson GR
    Eur J Pharmacol; 1989 Feb; 160(3):409-12. PubMed ID: 2565819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of N-methyl-D-aspartate receptors in dopamine D1-, but not D2-, mediated changes in striatal and accumbens neurotensin systems.
    Singh NA; Bush LG; Gibb JW; Hanson GR
    Brain Res; 1992 Feb; 571(2):260-4. PubMed ID: 1351780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute effects of D-1 and D-2 dopamine receptor agonist and antagonist drugs on basal ganglia [Met5]- and [Leu5]-enkephalin and neurotensin content in the rat.
    Taylor MD; de Ceballos ML; Jenner P; Marsden CD
    Biochem Pharmacol; 1991 May; 41(9):1385-91. PubMed ID: 1673340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine D2 receptors exert tonic regulation over discrete neurotensin systems of the rat brain.
    Merchant KM; Bush LG; Gibb JW; Hanson GR
    Brain Res; 1989 Oct; 500(1-2):21-9. PubMed ID: 2532557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The actions of (-)N-n-propylnorapomorphine and selective dopamine D1 and D2 receptor agonists to modify the release of [3H]dopamine from the rat nucleus accumbens.
    Barnes JM; Barnes NM; Costall B; Naylor RJ
    Neuropharmacology; 1990 Apr; 29(4):327-36. PubMed ID: 1971430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acetylcholine release in rat nucleus accumbens is regulated through dopamine D2-receptors.
    Wedzony K; Limberger N; Späth L; Wichmann T; Starke K
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Sep; 338(3):250-5. PubMed ID: 3264055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D-1 dopamine receptor stimulation enables the inhibition of nucleus accumbens neurons by a D-2 receptor agonist.
    White FJ
    Eur J Pharmacol; 1987 Mar; 135(1):101-5. PubMed ID: 3494620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulation of D2-receptors in rat nucleus accumbens slices inhibits dopamine and acetylcholine release but not cyclic AMP formation.
    Stoof JC; Verheijden PF; Leysen JE
    Brain Res; 1987 Oct; 423(1-2):364-8. PubMed ID: 2823991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of dopamine D-1 and D-2 receptor selective drugs on dopamine release and metabolism in rat striatum in vivo.
    Zetterström T; Sharp T; Ungerstedt U
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Oct; 334(2):117-24. PubMed ID: 2946964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine D-2 receptors inhibit D-1 stimulated cyclic AMP accumulation in striatum but not limbic forebrain.
    Kelly E; Nahorski SR
    Naunyn Schmiedebergs Arch Pharmacol; 1987 May; 335(5):508-12. PubMed ID: 2441268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissimilarities between cholinergic and dopaminergic turning elicited by nucleus accumbens stimulation in freely moving rats.
    Saigusa T; Koshikawa N; Kitamura M; Mizutani K; Kobayashi M; Cools AR
    Eur J Pharmacol; 1995 Feb; 274(1-3):213-20. PubMed ID: 7539377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors.
    Subramaniam S; Lucki I; McGonigle P
    Brain Res; 1992 Feb; 571(2):313-22. PubMed ID: 1351781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiological evidence for the existence of both D-1 and D-2 dopamine receptors in the rat nucleus accumbens.
    White FJ; Wang RY
    J Neurosci; 1986 Jan; 6(1):274-80. PubMed ID: 2868077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective blockade of dopamine D-1 receptor by SCH 23390 affects dopamine agonist binding to 3H-spiperone labeled D-2 receptors in rat striatum.
    Zhang X; Segawa T
    Jpn J Pharmacol; 1989 Jul; 50(3):333-45. PubMed ID: 2569545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of effects of D-1 and D-2 dopamine receptor agonists on neurons in the rat caudate putamen: an electrophysiological study.
    Hu XT; Wang RY
    J Neurosci; 1988 Nov; 8(11):4340-8. PubMed ID: 2972814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that the stimulatory effect of neurotensin on dopamine release in rat nucleus accumbens slices is independent of dopamine D2-receptor activation.
    Reyneke L; Russell VA; Taljaard JJ
    Brain Res; 1990 Nov; 534(1-2):188-94. PubMed ID: 1981481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticonvulsant effects of ipsilateral but not contralateral microinjections of the dopamine D2 agonist LY 171555 into the nucleus accumbens of amygdala-kindled rats.
    Wahnschaffe U; Löscher W
    Brain Res; 1991 Jul; 553(2):181-7. PubMed ID: 1681980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apomorphine affects cholecystokinin content via preferentially D1 or D2 dopamine receptor according to the regions of the rat brain.
    Yoshikawa T; Fukamauchi F; Shibuya H; Takahashi R
    Neuropeptides; 1989; 13(2):103-5. PubMed ID: 2567971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotensin-dopamine interactions in the substantia nigra of the rat brain.
    Merchant KM; Bush LG; Gibb JW; Hanson GR
    J Pharmacol Exp Ther; 1990 Nov; 255(2):775-80. PubMed ID: 2147039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.